The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Biomarkers: Potential uses and limitations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, cross-sectional studies cannot provide evidence for causality, and thus cannot distinguish causes from consequences secondarily to the illness [21].”
From Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis (2020) · cites this paper as [21]
In the citing paper
“Thus, most of the leading hypotheses are based on results from cross-sectional research, treatment studies, symptomatology studies, or animal studies (e.g.[8,12,16,18,20]), which cannot determine causality [21].”
From Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
Reiber, H., & Peter, J. B. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00501-3 · Cited by 731
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A. D., Hyman, B. T., Crain, B., Tang, M.-X., & Phelps, C. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380804 · Cited by 547 · cited 1×
“Many patients without an APOE- 4 allele develop Alzheimer’s disease and some individuals with an APOE- 4 allele do not develop this condition.(16)”
BackgroundSelf-citationE PIDEMIOLOGY OF N EURODEGENERATION
Mayeux, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 515
Self-citationCombining diagnostic test results to increase accuracy
Pepe, M. S. (2000) · Biostatistics · doi:10.1093/biostatistics/1.2.123 · Cited by 303
Molecular epidemiology : principles and practices
Schulte, P. A., & Perera, F. P. (1993) · Cited by 243
Molecular epidemiology: recent advances and future directions
Perera, F. P., & Weinstein, I. B. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.517 · Cited by 242
On the statistical analysis of ROC curves
Thompson, M. L., & Zucchini, W. (1989) · Statistics in Medicine · doi:10.1002/sim.4780081011 · Cited by 225
Biomarkers: current perspectives and future prospects
Naylor, S. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.5.525 · Cited by 182
Biological markers in epidemiology
Hulka, B. S., Wilcosky, T. C., & Griffith, J. D. (1990) · Oxford University Press eBooks · Cited by 171
Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases
Verbeek, M. M., de Jong, D., & Kremer, H. (2003) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456303321016141 · Cited by 99
Cited by
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400114 · Cited by 586
Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.13800 · Cited by 443
Medical Micro/Nanorobots in Precision Medicine
Soto, F., Wang, J., Ahmed, R., & Demirci, U. (2020) · Advanced Science · doi:10.1002/advs.202002203 · Cited by 442
Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis
Kennis, M., Gerritsen, L., van Dalen, M., Williams, A., Cuijpers, P., & Bockting, C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0585-z · Cited by 435
“However, cross-sectional studies cannot provide evidence for causality, and thus cannot distinguish causes from consequences secondarily to the illness [21].”
BackgroundTargeting non-coding RNAs to overcome cancer therapy resistance
Chen, B., Dragomir, M. P., Yang, C., Li, Q., Horst, D., & Calin, G. A. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00975-3 · Cited by 435
Ahmad, A., Imran, M., & Ahsan, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061630 · Cited by 386
Risk factors and biomarkers of age-related macular degeneration
Lambert, N. G., ElShelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., & Ambati, B. K. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.003 · Cited by 351
Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases
Kehm, R., Baldensperger, T., Raupbach, J., & Höhn, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101901 · Cited by 348
Bodaghi, A., Fattahi, N., & Ramazani, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13323 · Cited by 336
RetractedBiomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 321
Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease
Valenza, M., Rigamonti, D., Goffredo, D., Zuccato, C., Fenu, S., Jamot, L., Strand, A., Tarditi, A., Woodman, B., Racchi, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3355-05.2005 · Cited by 298
Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
Davey, M. G., Hynes, S. O., Kerin, M. J., Miller, N., & Lowery, A. J. (2021) · Cancers · doi:10.3390/cancers13174455 · Cited by 298
DNA Methylation Biomarkers: Cancer and Beyond
Mikeska, T., & Craig, J. (2014) · Genes · doi:10.3390/genes5030821 · Cited by 288
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224
Haslam, D. E., Li, J., Dillon, S. T., Gu, X., Cao, Y., Zeleznik, O. A., Sasamoto, N., Zhang, X., Eliassen, A. H., Liang, L., et al. (2022) · PROTEOMICS · doi:10.1002/pmic.202100170 · Cited by 157
“To identify robust clinical biomarkers, biomarker discovery should ideally leverage biological samples that are easy to collect, display little within-person variation over time, (except for biomarkers specifically linked to particular clinical phenotypes), and come from samples processed using various methods [13, 14…”
BackgroundFisher, M. (2005) · Stroke · doi:10.1161/01.str.0000173403.60553.27 · Cited by 156
Biomarkers of Pathological Dissociation: A Systematic Review
Roydeva, M. I., & Reinders, A. A. T. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.019 · Cited by 116
Hair cortisol concentrations in mental disorders: A systematic review
Koumantarou Malisiova, E., Mourikis, I., Darviri, C., Nicolaides, N. C., Zervas, I. M., Papageorgiou, C., & Chrousos, G. P. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113244 · Cited by 99
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature
Levitsky, J., Kandpal, M., Guo, K., Zhao, L., Kurian, S., Whisenant, T., & Abecassis, M. (2022) · Transplantation · doi:10.1097/tp.0000000000003895 · Cited by 36
“While not representing determinants of disease, they still may be connected to the causal pathway.(64) Ultimately, biological relevance can be an important consideration for using functional biomarkers in clinical practice.”
BackgroundLee, S., Kang, I. K., Kim, J. H., Jung, B. K., Park, K., Chang, H., Lee, J. Y., & Lee, H. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.2.14 · Cited by 27
Elhady, M., Youness, E. R., Gafar, H. S., Abdel Aziz, A., & Mostafa, R. S. I. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3448-5 · Cited by 19
Metadata
- Authors
- Mayeux, R.
- Venue
- NeuroRX
- Published
- 2004-04
- Volume
- 1
- Issue
- 2
- Pages
- 182-188
- ISSN
- 1545-5343 (ISSN-L)
- OpenAlex
- W2042990492
- Cited by
- 916
- References
- 16
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.